Bioxcel therapeutics to report third quarter 2023 financial results on november 14, 2023

New haven, conn., oct. 31, 2023 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will release its third quarter 2023 financial results on tuesday, november 14, 2023 before the open of the u.s. financial markets. bioxcel therapeutics' management team will also host a conference call and webcast at 8:00 am et that day to discuss the company's financial results and to provide a general business update.
BTAI Ratings Summary
BTAI Quant Ranking